PeptideHormone
The standard behind the catalog

Methodology & standards

PeptideHormone claims to be sourced, not asserted. This page is the receipt: how every monograph is referenced, how evidence is graded, how molecules are classified, and exactly where the reference stops and a clinician begins.

59 molecules · 12 signaling families · 119 peer-reviewed references

What this is

PeptideHormone is an independent, research-grade reference on the peptide hormone system — the endogenous signals that run the body and the engineered molecules redrawing the edge of research. It is a reference, not a store and not a clinic: no products, no storefront, no sponsored conclusions. The whole point of the project is to be the calm, checkable layer in a category that is loud with marketing and thin on rigor.

That only means something if the rigor is visible. Everything below is the method you can hold the rest of the site to.

How we source

Every monograph’s reference list was pulled live from PubMed through the NCBI E-utilities API, then vetted by hand for topical relevance. We lead with review articles and consensus statements rather than single primary studies — the goal is the settled center of a literature, not the most exciting outlier in it. Titles, journals, and years are carried through as PubMed returns them, and every citation exposes its PMID, which resolves at pubmed.ncbi.nlm.nih.gov. A claim you can’t click through to isn’t a claim we make.

One honest limit: monograph mechanisms summarize public literature, and summary means simplification. Active research is compressed into a few sentences; where a field is genuinely unsettled, we say so rather than manufacture a verdict.

The evidence ladder

Not all “peptide” claims are backed by the same weight of data, so we don’t present them as if they are. Every molecule carries an evidence tier — a filterable rigor badge — placing it on a five-rung ladder from settled science to sparse anecdote. The tier grades the strength of the evidence, not how interesting or promising the molecule is.

  1. Established

    Mechanism and core effects are settled across the peer-reviewed literature — typically endogenous hormones or approved drugs with decades of study behind them.

  2. Clinical

    Supported by human clinical trials, but still maturing, narrower in scope, or newer than the settled canon.

  3. Investigational

    Under active human investigation. The signal is promising, but the picture is not yet settled.

  4. Preclinical

    Evidence is largely animal or in-vitro. Human data is thin or absent — read the mechanism as a hypothesis, not a conclusion.

  5. Limited

    Sparse, older, or mostly community-reported evidence. These carry the loudest claims and the least data — treat them with the most caution.

The badge grades the weight of the evidence — not how promising the molecule is.

How molecules are classified

Alongside the evidence tier, each entry is tagged by what kind of molecule it actually is — because “peptide” spans everything from a hormone your gut secretes to a compound that has never seen a registered trial:

  • Endogenousa signal the body produces itself — the native biology the rest of the catalog is measured against.
  • Analogan engineered molecule built on an endogenous hormone, tuned for potency, half-life, or receptor selectivity.
  • Researcha community "research peptide" that sits outside the approved-drug system — where the evidence is often thinnest and the claims loudest.

Reading the two tags together is the point. An endogenous molecule graded Established and a research molecule graded Limited are both in the catalog — the labels tell you, at a glance, how far to trust what follows.

The standard, in one line

A page here earns its place by citation and by honest grading — not by confident tone. Where the evidence is thin, the badge says so; where the science is unsettled, the text says so. That is the whole difference between a reference and a sales page.

Research-grade, not medical

This is reference material for understanding biology. It is not medical advice, not dosing guidance, not a diagnosis, and not a recommendation to obtain or use any compound. Nothing here substitutes for a licensed clinician who knows your situation. Regulatory status varies by jurisdiction and by whether a given compound is handled as an approved drug or a research reagent — a distinction that is your responsibility to check, not ours to wave away.

We hold this line deliberately. The moment a reference starts telling you what to take, it has stopped being a reference.

Independence & funding

PeptideHormone sells nothing and hosts no storefront. There are no sponsored monographs and no conclusions bent to a seller’s interest — the incentive is to be correct, not to move product. If that ever changes — if any funding, affiliate, or commercial relationship enters the picture — it will be disclosed here, plainly, before it touches a single word of the catalog.

Corrections & contact

A reference is only as good as its willingness to be wrong in public. If you find an error — a misread mechanism, a stale reference, a mis-graded tier — tell us and we will fix it or show our work.

Corrections and questions: corrections@peptidehormone.com

Include the molecule or page and, where you can, a PMID or link — it gets the fix out faster.

Educational reference only — not medical advice, diagnosis, or treatment, and not an endorsement of any purchase or use. Evidence tiers and molecule classes are editorial judgments about the public literature and can change as the science does.